Prediction market event contracts on both clinical drug trials and Food and Drug Administration regulatory approvals are drawing attention from two Democratic senators, according to a letter obtained first by CNBC. Sen. Angela Alsobrooks , D-Md., and Sen. Ron Wyden , D-Ore., expressed concern over the related event contracts in a Wednesday letter to Department of Health and Human Services Secretary Robert F. Kennedy Jr . The senators asked what measures HHS has taken to mitigate any risks that may arise from the markets.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.